Professor of Kaohsiung Chang Gung Memorial Hospital
Research primarily focuses on hepatocellular carcinoma (HCC) and gastrointestinal stromal tumors (GIST).
Considered a pioneer in the study of the PTEN-AKT signaling pathway in liver cancers in Taiwan.
Significant contributions to understanding the molecular basis of GIST in Taiwan.
Interests also encompass the treatment of hepatitis B and C, as well as antiviral therapies post-liver transplantation.
Has established predictive models for HCC development after antiviral therapies, particularly for individuals with sustained virological response.
Explores the impact of antiviral therapies such as telbivudine, entecavir, and tenofovir on kidney function.
Actively involved in community-based HCC screening and hepatitis C micro-elimination efforts in Changhua County, Taiwan.
Boasts a substantial publication record, including 288 academic papers in peer-reviewed journals and 68 papers as the first or corresponding author, in addition to one book chapter.
Has served as the principal investigator for 36 research grants and 34 clinical trial programs.
台湾Kaohsiung Chang Gung Memorial Hospital(高雄長庚紀念病院)内科の教授